|
Project detail:
The project involves an equity investment of up to USD 125 million in OrbiMed Asia Partners VI, L.P. The fund aims to make growth-equity investments in 20–25 healthcare companies, with approximately 40% of committed capital allocated each to India and the PRC, and up to 20% potentially invested elsewhere in Asia. The investment is intended to support healthcare companies producing/distributing medicines for tier II/III cities and rural or peri-urban markets, providing healthcare services to low-income segments, or developing healthcare products/services for underserved populations.
Project Cost: USD 125 million (ADB proposed equity investment)
Note: please download project document attached to this project for more information.
|